148 related articles for article (PubMed ID: 36313290)
1. NEUROD1 predicts better prognosis in pancreatic cancer revealed by a TILs-based prognostic signature.
Jiang Z; Pan J; Lu J; Mei J; Xu R; Xia D; Yang X; Wang H; Liu C; Xu J; Ding J
Front Pharmacol; 2022; 13():1025921. PubMed ID: 36313290
[TBL] [Abstract][Full Text] [Related]
2. Construction of a 6-gene prognostic signature to assess prognosis of patients with pancreatic cancer.
Yang J; Shi W; Zhu S; Yang C
Medicine (Baltimore); 2020 Sep; 99(37):e22092. PubMed ID: 32925750
[TBL] [Abstract][Full Text] [Related]
3. A DNA-Methylation-Driven Genes Based Prognostic Signature Reveals Immune Microenvironment in Pancreatic Cancer.
Xiao M; Liang X; Yan Z; Chen J; Zhu Y; Xie Y; Li Y; Li X; Gao Q; Feng F; Fu G; Gao Y
Front Immunol; 2022; 13():803962. PubMed ID: 35222383
[TBL] [Abstract][Full Text] [Related]
4. Identification of a Nine-Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival of Pancreatic Cancer.
Wu M; Li X; Zhang T; Liu Z; Zhao Y
Front Oncol; 2019; 9():996. PubMed ID: 31612115
[No Abstract] [Full Text] [Related]
5. Construction of a novel prognostic signature based on the composition of tumor-infiltrating immune cells in clear cell renal cell carcinoma.
Yu W; Lu J; Wu C
Front Genet; 2022; 13():1024096. PubMed ID: 36313434
[TBL] [Abstract][Full Text] [Related]
6. Identification and Validation of T-Cell Exhaustion Signature for Predicting Prognosis and Immune Response in Pancreatic Cancer by Integrated Analysis of Single-Cell and Bulk RNA Sequencing Data.
Zhu Y; Tan L; Luo D; Wang X
Diagnostics (Basel); 2024 Mar; 14(6):. PubMed ID: 38535087
[TBL] [Abstract][Full Text] [Related]
7. The Prognostic Significance of the Tumor-infiltrating Programmed Cell Death-1
Shibutani M; Maeda K; Nagahara H; Fukuoka T; Nakao S; Matsutani S; Hirakawa K; Ohira M
Anticancer Res; 2017 Aug; 37(8):4165-4172. PubMed ID: 28739701
[TBL] [Abstract][Full Text] [Related]
8. Prognostic alternative splicing signature reveals the landscape of immune infiltration in Pancreatic Cancer.
Wang L; Bi J; Li X; Wei M; He M; Zhao L
J Cancer; 2020; 11(22):6530-6544. PubMed ID: 33046974
[No Abstract] [Full Text] [Related]
9. Magnetic resonance imaging and molecular features associated with tumor-infiltrating lymphocytes in breast cancer.
Wu J; Li X; Teng X; Rubin DL; Napel S; Daniel BL; Li R
Breast Cancer Res; 2018 Sep; 20(1):101. PubMed ID: 30176944
[TBL] [Abstract][Full Text] [Related]
10. Identification and characterization of a 25-lncRNA prognostic signature for early recurrence in hepatocellular carcinoma.
Fu Y; Wei X; Han Q; Le J; Ma Y; Lin X; Xu Y; Liu N; Wang X; Kong X; Gu J; Tong Y; Wu H
BMC Cancer; 2021 Oct; 21(1):1165. PubMed ID: 34717566
[TBL] [Abstract][Full Text] [Related]
11. Protein-based prognostic signature for predicting the survival and immunotherapeutic efficiency of endometrial carcinoma.
Lai J; Xu T; Yang H
BMC Cancer; 2022 Mar; 22(1):325. PubMed ID: 35337291
[TBL] [Abstract][Full Text] [Related]
12. Construction of mRNA prognosis signature associated with differentially expressed genes in early stage of stomach adenocarcinomas based on TCGA and GEO datasets.
Jiang F; Lin H; Yan H; Sun X; Yang J; Dong M
Eur J Med Res; 2022 Oct; 27(1):205. PubMed ID: 36253873
[TBL] [Abstract][Full Text] [Related]
13. Construction of a Pyroptosis-Related Genes Signature to Improve the Prognostic Prediction and Therapeutic Drugs Selection in Patients with Pancreatic Cancer.
Li C; Wang M; Wei J; Zhang W; Liu H; Zhao D
Int J Gen Med; 2022; 15():6387-6403. PubMed ID: 35942290
[TBL] [Abstract][Full Text] [Related]
14. The prognostic value of tumour-infiltrating lymphocytes in pancreatic cancer: a systematic review and meta-analysis.
Orhan A; Vogelsang RP; Andersen MB; Madsen MT; Hölmich ER; Raskov H; Gögenur I
Eur J Cancer; 2020 Jun; 132():71-84. PubMed ID: 32334338
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of tumor-infiltrating lymphocytes in nondisseminated nasopharyngeal carcinoma: A large-scale cohort study.
Wang YQ; Chen YP; Zhang Y; Jiang W; Liu N; Yun JP; Sun Y; He QM; Tang XR; Wen X; Yang XJ; Zhang PP; Zhang J; Lei Y; Li YQ; Ma J
Int J Cancer; 2018 Jun; 142(12):2558-2566. PubMed ID: 29377121
[TBL] [Abstract][Full Text] [Related]
16. Discovery and Validation of Circulating EVL mRNA as a Prognostic Biomarker in Pancreatic Cancer.
Du Y; Yao K; Feng Q; Mao F; Xin Z; Xu P; Yao J
J Oncol; 2021; 2021():6656337. PubMed ID: 33986805
[TBL] [Abstract][Full Text] [Related]
17. Exploration of a Robust and Prognostic Immune Related Gene Signature for Cervical Squamous Cell Carcinoma.
Zuo Z; Xiong J; Zeng C; Jiang Y; Xiong K; Tao H; Guo Y
Front Mol Biosci; 2021; 8():625470. PubMed ID: 33748188
[No Abstract] [Full Text] [Related]
18. Prognostic significance of FOXP3+ tumor-infiltrating lymphocytes in breast cancer depends on estrogen receptor and human epidermal growth factor receptor-2 expression status and concurrent cytotoxic T-cell infiltration.
Liu S; Foulkes WD; Leung S; Gao D; Lau S; Kos Z; Nielsen TO
Breast Cancer Res; 2014 Sep; 16(5):432. PubMed ID: 25193543
[TBL] [Abstract][Full Text] [Related]
19. Density and location of CD3
Zhou C; Wu Y; Jiang L; Li Z; Diao P; Wang D; Zhang W; Liu L; Wang Y; Jiang H; Cheng J; Yang J
J Oral Pathol Med; 2018 Apr; 47(4):359-367. PubMed ID: 29469989
[TBL] [Abstract][Full Text] [Related]
20. Prognostic impact of programed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor infiltrating lymphocytes in colorectal cancer.
Li Y; Liang L; Dai W; Cai G; Xu Y; Li X; Li Q; Cai S
Mol Cancer; 2016 Aug; 15(1):55. PubMed ID: 27552968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
